One medicine that experts in the Japanese government panel have expressed hope in is Ciclesonide (marketed as Alvesco), a type of steroid used in inhalers to treat asthma. A medical team including members of the Kanagawa Prefectural Ashigarakami Hospital administered this drug to three coronavirus disease patients. One of them, a woman in her 70s, saw her fever go down after two days, and her pneumonia symptoms also improved. She later tested negative for the virus and was discharged from hospital after eight days. The other two patients, a man in his 70s and a woman in her 60s, were able to be taken off respirators after receiving the medicine. Currently around 10 people are receiving it.
The National Institute of Infectious Diseases (NIID) reported that Ciclesonide was given to patients with the new coronavirus disease, COVID-19, after being found to have some effect in the treatment of Middle East Respiratory Syndrome (MERS), which is caused by another type of coronavirus. The drug is said to control inflammation and block multiplication of the virus.
https://mainichi.jp/english/articles/20200317...Nzf9kXh8AU